Association of physical activity with bleeding events and safety in patients with haemophilia A starting emicizumab prophylaxis: an interim analysis of the TSUBASA study

CONCLUSIONS: PwHA receiving emicizumab in the TSUBASA study experienced minimal bleeding associated with physical activity.TRIAL REGISTRATION: Trial registration: UMIN-CTR ID: UMIN000037448.PMID:38100026 | DOI:10.1007/s12185-023-03679-8

Source: International Journal of Hematology - December 15, 2023 Category: Hematology Authors: Keiji Nogami Teruhisa Fujii Akihiro Sawada Azusa Nagao Chiai Nagae Masanori Nojima Nobuaki Suzuki Daisuke Nosaka Tomomi Shimura Yoshimasa Sugao Kagehiro Amano Source Type: research